BAM
FLNA

Byrne Asset Management’s Filana Therapeutics FLNA Stock Holding History

Byrne Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40
Closed -$79 – 602
2025
Q4 		$79 Hold
40
– – ﹤0.01% 550
2025
Q3 		$116 Hold
40
– – ﹤0.01% 554
2025
Q2 		$72 Hold
40
– – ﹤0.01% 536
2025
Q1 		$60 Sell
40
-5,250
-99% -$13.2K ﹤0.01% 552
2024
Q4 		$12.5K Buy
5,290
+4,365
+472% +$76.7K 0.01% 362
2024
Q3 		$27.2K Sell
925
-2,610
-74% -$60.1K 0.02% 264
2024
Q2 		$67K Sell
3,535
-85
-2% -$1.79K 0.05% 183
2024
Q1 		$73.5K Buy
3,620
+270
+8% +$6.22K 0.05% 180
2023
Q4 		$75.4K Buy
+3,350
New +$70.8K 0.06% 168
2023
Q3 		– Sell
-2,290
Closed -$45.4K – 203
2023
Q2 		$56K Buy
2,290
+345
+18% +$8.31K 0.04% 234
2023
Q1 		$47K Sell
1,945
-749
-28% -$20.8K 0.03% 230
2022
Q4 		$79.6K Buy
2,694
+511
+23% +$18.4K 0.06% 195
2022
Q3 		$91K Sell
2,183
-128
-6% -$3.46K 0.07% 165
2022
Q2 		$73K Sell
2,311
-1,230
-35% -$31.1K 0.05% 165
2022
Q1 		$132K Buy
3,541
+1,383
+64% +$58.6K 0.08% 141
2021
Q4 		$94K Buy
+2,158
New +$113K 0.06% 172

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Byrne Asset Management's FLNA Position: Q1 2026 in Review

Byrne Asset Management sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 40 shares — an estimated $79 sold.

Byrne Asset Management first reported a position in FLNA in Q4 2021 and held it in 16 quarters. The position peaked at $132K in Q1 2022. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Byrne Asset Management reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Byrne Asset Management sold 40 Filana Therapeutics shares in Q1 2026, an estimated $79.
  • Byrne Asset Management first reported a position in Filana Therapeutics in Q4 2021 and held it in 16 quarters.
  • Byrne Asset Management's Filana Therapeutics position peaked at $132K in Q1 2022.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Byrne Asset Management's 13F filing for Q1 2026, filed 2 Apr 2026.